endocrine system
DESCRIPTION
Endocrine System. PART II. DISORDERS OF THE GONADS. NOONAN SYNDROME. SHORT STATURE, webbing of the neck, pectus carinatum / excavatum , cubitus valgus , R sided congenital HD, characteristic facies . - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/1.jpg)
Endocrine System
PART II
![Page 2: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/2.jpg)
DISORDERS OF THE GONADS
![Page 3: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/3.jpg)
NOONAN SYNDROME
• SHORT STATURE, webbing of the neck, pectus carinatum/excavatum, cubitus valgus, R sided congenital HD, characteristic facies.
• Hypertelorism, epicanthus, downward slanted palpebral fissures, ptosis, micrognathia, ear abnormalities
• Mean IQ 86 (53-127)• Verbal IQ> performance IQ
![Page 4: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/4.jpg)
NOONAN SYNDROME• PULMONARY VALVULAR STENOSIS, HYPERTROPHIC CM,
ASD• Hepatosplenomegaly, low clotting factors XI XII, ALL, CML• CRYPTORHIDISM, SMALL TESTES, hypogonadal or normal• Delayed puberty (2yrs), ADULT HEIGHT 2nd DECADE, usually
reaches the lowest limit of the normal population• PRENATAL DX: Normal karyotype, edema, hydrops and
short femur length• TREATMENT: HUMAN GH
![Page 5: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/5.jpg)
KLINEFELTER SYNDROME• 1/500 MALES: 47,XXY• ALL BOYS WITH MR and in children with PSYCHOSOCIAL,
LEARNING, or SCHOOL ADJUSTMENT problems• Tall, slim, underweight, long legs, body habitus can vary
markedly• Testes tend to be small for age, phallus tends to be smaller
than average, cryptorchidism or hypospadias may occur in a few patients; SPERMATOGENIC ARREST and SERTOLI CELL PREDOMINANCE
• GYNECOMASTIA (80%)• Height tends to be increased
![Page 6: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/6.jpg)
12-yr-old boy with 48,XXXY/49,XXXXY mosaicism who has prognathism, epicanthal folds, scoliosis, small testes, severe mental retardation, clinodactyly, and radioulnar synostoses
![Page 7: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/7.jpg)
KLINEFELTER SYNDROME
• Increased incidence of pulmonary disease, varicose veins, cancer of the breast
• Male breast cancer (7.5%), Mediastinal GCT, Leukemia, Lymphoma. Higher cancer risk (RR 2.7): 15-30y age group
![Page 8: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/8.jpg)
KLINEFELTER SYNDROME
• Replacement therapy– Long-acting TESTOSTERONE preparation– 11-12 yrs of age– ENANTHATE ESTER 25-50mg IM q3-4w, 50mg increments q6-9mo until a maintenance
dose for adults achieved (200-250mg q3-4w)– TESTOSTERONE PATCHES/GEL
• Rapid increase in prostate volume and PSA levels
![Page 9: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/9.jpg)
HYPOGONADOTROPIC HYPOGONADISM in the MALE
(SECONDARY HYPOGONADISM)• Deficiency of LH or FSH, or both• Primary defect: anterior pituitary/ hypothalamus – deficiency of GnRH• N testes, prepubertal • KALLMAN SYNDROME - +anosmia/hyposmia
– Xlinked mutation KAL gene – failure of the olfactory axons and GnRH-expressing neurons to migrate from their common origin in the olfactory placode to the brain
• TESTOSTERONE ENANTHATE 100mg IM qMo for 4-6mo increase in signs of secondary sexual characteristics, increase in growth velocity
• hCG 500-1000IU, SC or IM, 3x/wk growth of testes and spermatogenesis
• human menopausal gonadotrophin 37.5-150 IU, 3x/wk, may require 2yrs of tx
![Page 10: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/10.jpg)
PSEUDOPRECOCITY resulting from Tumors of the testes
• Leydig Cell Tumors – REINKE CRYSTALLOIDS• Adrenal Rest Tumors– bilateral
• FRAGILE X SYNDROME– B Testicular enlargement MACROORCHIDISM, 40-
50mL
![Page 11: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/11.jpg)
GYNECOMASTIA
• TRUE vs PSEUDOGYNECOMASTIA (adipose)• ESTROGEN-ANDROGEN IMBALANCE• Aromatase• Treatment: Reassurance– Medical: Anastrozole (Ar In) 1mg = placebo– Surgical: Removal ENDOSCOPICALLY ASSISTED
TRANSAXILLARY REMOVAL
![Page 12: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/12.jpg)
HYPOFUNCTION OF THE OVARIESTURNER SYNDROME
• Sexual infantilism, webbed neck, cubitus valgus• Complete or partial absence of second X chr• BIRTH: edema of dorsum of hands & feet, loose skin
folds at the nape. LOW BW and DECREASED LENGTH• CHILDHOOD: webbing of the neck, low posterior
hairline, small mandible, prominent ears, epicanthal folds, high arched palate, broad chest, cubitus valgus, hyperconvex fingernails
• SHORT STATURE (US MAH: 143-144cm), MPH
![Page 13: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/13.jpg)
Turner syndrome in a 15-yr-old girl exhibiting failure of sexual maturation, short stature, cubitus valgus, and a goiter. There is no webbing of the neck. Karyotyping revealed 45,X/46,XX chromosome complement
![Page 14: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/14.jpg)
TURNER SYNDROME
• Isolated nonstenotic bicuspid aortic valves, aortic coarctation, AS, MVP
• Pelvic kidney, horseshoe kidney, double collecting system, complete absence of 1kidney, UPJ obstruction
• Autoimmune thyroid disease• IBD: Chron disease and UC• Sternal malformations• Recurrent Bilateral OM, SNH defects
![Page 15: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/15.jpg)
TURNER SYNDROME
• Chromosomal Analysis• Ultrasonography• Plasma Gn: FSH• Thyroid antiPO Ab, T4, TSH• Treatment: RECOMBINANT hGH– Replacement E2 Therapy• Conjugated estrogen 0.3-0.625mg• Micronized E2 0.5mg daily x3-6mo
![Page 16: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/16.jpg)
CONGENITAL ADRENAL HYPERPLASIA
• Ambiguous genitalia• 21-OH deficiency
![Page 17: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/17.jpg)
Cholesterol
Pregnelonone Progesterone DOC Corticosterone 180H Corticosterone
Aldosterone
170H Pregnenolone
170H Progesterone 11 Deoxycortisol Cortisol
DHEA Androstenedione Testosterone Estradiol
P450sccP450c213(B)HSD P450c11 P450c11 P450c11
P450c17 P450c17
3(B)HSD
P450c21 P450c113(B)HSD
17(B)HSD P450aro
![Page 18: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/18.jpg)
CONGENITAL ADRENAL HYPERPLASIA
• SALT WASTING • Progressive weight loss, anorexia, vomiting,
dehydration, weakness, hypOtension, hypOglycemia, hypOnatremia, hypErkalemia
• 2 Wks of age• GLUCOCORTICOID 15-20mg/m²/24 • FLUDROCORTISONE 0.1-0.3mg/day
![Page 19: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/19.jpg)
WAGRWILMS TUMOR, ANIRIDIA,
GENITOURINARY MALFORMATIONS, RETARDATION
• Deletion c11p13 (aniridia gene PAX6, WT1)• 46,XY males have genital abnormalities• Cryptorchidism• Virilization
![Page 20: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/20.jpg)
ANDROGEN INSENSITIVITY SYNDROMES
• 46,XY• Phenotypic females (COMPLETE AIS) to males with various
ambiguous genitals and undervirilization (PARTIAL)• Complete: female at birth, F external genitals, blind vaginal
pouch, absent uterus, FT remnants, intraabdominal testes. – Puberty: N breast development, female habitus, menstruation
does not occur, absent sexual hair– Adult height same with N males– N testosterone and DHT levels– Testicular removal (seminoma); ESTROGEN
![Page 21: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/21.jpg)
DIABETES MELLITUS
![Page 22: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/22.jpg)
Type 1 DM
• IDDM, juvenile diabetes• Low/ absent levels of endogenously produced insulin
and dependence on exogenous insulin to prevent DKA• 4 stages:
1. Preclinical β-cell autoimmunity with progressive defect of insulin secretion
2. Onset of clinical diabetes3. Transient remission “honeymoon period”4. Established diabetes associated with acute and chronic
complications and decreased life expectancy
![Page 23: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/23.jpg)
Type 1 DM
• Onset: 7-15 y/o• Autoimmune destruction
![Page 24: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/24.jpg)
T2 DM
• Usually obese but are not insulin dependent• NIDDM, adult-onset DM, MODY• More insidious• Excessive weight gain, fatigue• ACANTHOSIS NIGRICANS
![Page 25: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/25.jpg)
T2 DM CRITERIA• OVERWEIGHT (BMI>85th % A,S; WFH>85th %; Wt>120% of ideal for ht)
PLUS:
Any 2 of the ff:• FH T2DM in 1st or 2nd degree relative• Race/Ethnicity• Signs of Insulin Resistance or conditions associated with insulin resistance (AN,
hypertension, dyslipidemia, PCOS)• Age of initiation: age 10yrs or at onset of puberty if puberty occurs at a younger
age• Frequency: every 2 yrs• Test: FPG preferred
![Page 26: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/26.jpg)
TreatmentInsulin therapy
prepubertal 0.7 U/Kg/dmidpuberty 1.0 U/Kg/dend 1.2 U/Kg/d
Nutritional EducationImproved Exercise Level
Diagnosis• “inappropriate polyuria in any child with dehydration,
poor weight gain, or the flu”• RBS>200mg/dL (11.1
![Page 27: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/27.jpg)
Long Term Complications
1. Microvascular– Retinopathy– Nephropathy
2. Macrovascular– CAD– CVD– PVD
3. Neuropathies– Peripheral– Autonomic
![Page 28: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/28.jpg)
TRANSIENT DM of the NEWBORN
• 1st week of life• SGA• Hyperglycemia, pronounced glycosuria• Severe dehydration, metabolic acidosis but
with only minimal or no ketonemia/ketonuria• 1-2U/Kg/24h intermediate actingINSULIN
insulin
![Page 29: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/29.jpg)
DEFECTS OF CARBOHYDRATE METABOLISM
![Page 30: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/30.jpg)
Glycogen Storage Disease type I (GLUCOSE-6-PHOSPHATASE/ TRANSLOCASE/ VON GIERKE DISEASE)
• Neonatal period: Hypoglycemia and lactic acidosis• 3-4mo: hepatomegaly, hypoglycemic seizures• Doll like faces with fat cheeks, relatively thin
extremities, short stature, protruberant abdomen, enlarged kidneys
• Hypoglycemia, Lactic Acidosis, Hyperuricemia, Hyperlipidemia
• NORMAL transaminases• Tx: NGT infusion of glucose/ oral uncooked cornstarch
![Page 31: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/31.jpg)
Glycogen Storage Disease type III (DEBRANCHER DEFICIENCY)
• Deficiency of glycogen debranching enzyme activity• Hepatomegaly, hypoglycemia, short stature,
variable skeletal myopathy, variable CM• BOTH LIVER AND MUSCLE INVOLVEMENT (IIIa)• LIVER (IIIb)• ELEVATION OF LIVER TRANSAMINASES• HEPATOCELLULAR CARCINOMA• Tx: Frequent meals with high in CHO, high CHON
diet
![Page 32: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/32.jpg)
GSDIIIbGrowth and development in a patient with type IIIb glycogen storage disease. The patient has debrancher deficiency in liver but normal activity in muscle. As a child, he had hepatomegaly, hypoglycemia, and growth retardation. After puberty, he no longer had hepatomegaly or hypoglycemia, and his final adult height is normal.He had no muscle weakness or atrophy; this is in contrast to type IIIa patients, in whom a progressive myopathy is seen in adulthood.
![Page 33: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/33.jpg)
Glycogen Storage Disease type IV(Branching Enzyme Deficiency/ Amylopectinosis/ Andersen Disease)
• Accumulation of an abnormal glycogen with poor solubility
• Fewer branch points• Progressive cirrhosis of the liver• 1st 18 mo: hepatosplenomegaly, FTT• Cirrhosis progresses to portal HPN, ascites,
esophageal varices, liver failure• Death by 5 y/o• NO SPECIFIC TX, poor prognosis
![Page 34: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/34.jpg)
Glycogen Storage Disease type II (LYSOSOMAL ACID a1-4-GLUCOSIDASE DEFICIENCY/ POMPE DISEASE)
• Lysosomal glycogen accumulation in multiple tissues, cardiac, skeleletal, SMOOTH MUSCLE CELLS
• Myopathy, “floppy infant appearance”, feeding difficulties, macroglossia, hepatomegaly, hypertrophic CM
• Slowly progressive proximal muscle weakness with truncal involvement
• LE> UE• Lab: elevated CK, AST, LDH; muscle def a-glucosidase• Tx: Supportive/ Palliative
![Page 35: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/35.jpg)
GALACTOSEMIA (Galactose-1-Phosphate Uridyl Transferase Deficiency)
• 2nd half of the 1st week of life• Accumulation of galactose-1-phosphate
kidney/liver/brain injury• Jaundice, hepatomegaly, vomiting, hypoglycemia,
convulsions, lethargy, irritability, feeding difficulties, FTT, aminoaciduria, nuclear cataracts, vitreous hge, hepatic failure, liver cirrhosis, ascites, splenomegaly, mental retardation.
• Dx: Reducing substance in urine• Tx: Elimination of galactose from the diet
![Page 36: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/36.jpg)
MUCOPOLYSACCHARIDOSIS IHURLER DISEASE
• 6 to 24 months old• Hepatosplenomegaly, coarse facial features,
corneal clouding, large tongue, prominent forehead, joint stiffness, short stature and skeletal dysplasia, developmental delay
![Page 37: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/37.jpg)
MUCOPOLYSACCHARIDOSIS IIHUNTER DISEASE
• Almost exclusively in MALES• Same with Hurler EXCEPT for LACK OF
CORNEAL CLOUDING and somewhat SLOWER progression of somatic and CNS deterioration
![Page 38: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/38.jpg)
![Page 39: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/39.jpg)
MUCOPOLYSACCHARIDOSIS
• Treatment– BM transplantation– CORD BLOOD transplantation– Enzyme replacement
![Page 40: Endocrine System](https://reader035.vdocument.in/reader035/viewer/2022070423/56816690550346895dda6946/html5/thumbnails/40.jpg)
Thank You